Disclosure statement
ER is an advisor for Daiichi-Sankyo, Astellas, Abbvie, Celgene and Pfizer; PYD is an advisor for Daiichi-Sankyo, Astellas; PP is an advisor for Jazz, Daiichi-Sankyo, Abbvie and Astellas; MOJ has received honoraria for advisory board from Daichii-Sankyo; AP has received grants from Roche, Celgene, Sunesis, Novartis, Jazz, AbbVie, Astellas, Daiichi-Sankyo and is an advisor for Roche, Celgene, Sunesis, Amgen, Novartis, Jazz, AbbVie, Astellas, Daiichi-Sankyo, Sanofi, Pfizer; CR has received research grants from Amgen, Novartis, Celgene, Jazz Pharmaceuticals, Agios, Chugai, Sunesis, Astellas, and MaatPharma and is an advisor for AbbVie, Sunesis, Janssen, Jazz, Novartis, Celgene, Astellas, Daiichi-Sankyo, Macrogenics, and Pfizer; SB is an advisor for Jazz, Daiichi-Sankyo, Sanofi, and Astellas.